Buscador de publicacions

Publicacions

  • Gavalda A, Pastor JJ, Mereu A, Villarroya F and Ipharraguerre IR.

    Developmental regulation of the intestinal FGF19 system in domestic pigs.

    AM J PHYSIOL-GASTR L . 314(6): . Nº de cites: 7

    [doi:10.1152/ajpgi.00312.2017]

  • Domingo P, Gallego-Escuredo JM, Fernández I, Villarroya J, Torres F, Del Mar Gutierrez M, Mateo MG, Villarroya F, Vidal F, Giralt M and Domingo JC.

    Effects of docosahexanoic acid supplementation on inflammatory and subcutaneous adipose tissue gene expression in HIV-infected patients on combination antiretroviral therapy (cART). A sub-study of a randomized, double-blind, placebo-controlled study.

    Cytokine . 105: 73-79. Nº de cites: 12

    [doi:10.1016/j.cyto.2018.02.008]

  • Pellitero S, Piquer-Garcia I, Ferrer-Curriu G, Puig R, Martínez Franco E, Moreno P, Tarascó J, Balibrea J, Lerin-Martinez C, Puig-Domingo M, Villarroya F, Planavila A and Sánchez-Infantes D.

    Opposite changes in meteorin-like and oncostatin m levels are associated with metabolic improvements after bariatric surgery.

    INTERNATIONAL JOURNAL OF OBESITY . 42(4): 919-922. Nº de cites: 19

    [doi:10.1038/ijo.2017.268]

  • Zarei M, Barroso E, Palomer FX, Dai J, Rada P, Quesada T, Escolà-Gil JC, Cedó L, Zali MR, Molaei M, Dabiri R, Vázquez S, Pujol E, Valverde ÁM, Villarroya F, Liu Y, Wahli W and Vazquez M.

    Hepatic regulation of VLDL receptor by PPARß/d and FGF21 modulates non-alcoholic fatty liver disease.

    molecular metabolism . 8: 117-131. Nº de cites: 39

    [doi:10.1016/j.molmet.2017.12.008]

  • de Sousa-Malpique RM, Bassols J, López-Bermejo A, Díaz-Silva M, Villarroya F, Pavia J, Congo A, de Zegher F and Ibañez-Toda L.

    Liver volume and hepatic adiposity in childhood: relations to body growth and visceral fat.

    INTERNATIONAL JOURNAL OF OBESITY . 42(1): 65-71. Nº de cites: 6

    [doi:10.1038/ijo.2017.198]

  • Villarroya F, Gavalda A, Peyrou M, Villarroya J and Giralt M.

    The Lives and Times of Brown Adipokines.

    TRENDS IN ENDOCRINOLOGY AND METABOLISM . 28(12): 855-867. Nº de cites: 44

    [doi:10.1016/j.tem.2017.10.005]

  • Fourcade S, Morató L, Parameswaran J, Ruiz M, Ruiz-Cortés T, Jové M, Naudí A, Martínez-Redondo P, Dierssen M, Ferrer I, Villarroya F, Pamplona R, Vaquero A, Portero-Otín M and Pujol A.

    Loss of SIRT2 leads to axonal degeneration and locomotor disability associated with redox and energy imbalance.

    Aging Cell . 16(6): 1404-1413. Nº de cites: 22

    [doi:10.1111/acel.12682]

  • Redondo-Angulo I, Mas-Stachurska A, Sitges M, Tinahones FJ, Giralt M, Villarroya F and Planavila A.

    Fgf21 is required for cardiac remodeling in pregnancy.

    CARDIOVASC RES . 113(13): 1574-1584. Nº de cites: 20

    [doi:10.1093/cvr/cvx088]

  • Martínez-Sánchez N, Seoane-Collazo P, Contreras C, Varela L, Villarroya J, Rial-Pensado E, Buqué X, Aurrekoetxea I, Delgado TC, Vázquez-Martínez R, González-García I, Roa J, Whittle AJ, Gomez-Santos B, Velagapudi V, Tung YCL, Morgan DA, Voshol PJ, Martínez de Morentin PB, López-González T, Liñares-Pose L, Gonzalez F, Chatterjee K, Sobrino T, Medina-Gómez G, Davis RJ, Casals N, Orešic M, Coll AP, Vidal-Puig A, Mittag J, Tena-Sempere M, Malagón MM, Diéguez C, Martínez-Chantar ML, Aspichueta P, Rahmouni K, Nogueiras R, Sabio G, Villarroya F and López M.

    Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance.

    CELL METABOLISM . 26(1): . Nº de cites: 118

    [doi:10.1016/j.cmet.2017.06.014]

  • Gallego-Escuredo JM, Lamarca MK, Villarroya J, Domingo JC, Mateo MG, Gutierrez MDM, Vidal F, Villarroya F, Domingo P and Giralt M.

    High FGF21 levels are associated with altered bone homeostasis in HIV-1-infected patients.

    METABOLISM-CLINICAL AND EXPERIMENTAL . 71: 163-170. Nº de cites: 9

    [doi:10.1016/j.metabol.2017.03.014]